Calico Life Sciences ยท 1 week ago
Intern, Protein Biochemistry, Tumor and E3-ligase Biology (PhD Student)
Calico Life Sciences is a research and development company focused on understanding human aging and developing interventions for healthier lives. They are seeking an intern to join the Nile Lab, where the intern will gain hands-on experience in drug development and assist in characterizing novel E3-ligases through various biochemical and cellular assays.
Biotechnology
Responsibilities
Perform and design biophysical assays
Conduct and/or develop biochemical assays
Perform mammalian tissue culture maintenance and assays
Maintain accurate experimental records
Attend weekly 1:1 meetings and participate in team discussions
Qualification
Required
Currently pursuing a PhD in Cell Biology, Biochemistry, Chemistry, or a related field
Hands-on experience with basic laboratory techniques (e.g., pipetting, solution preparation, record keeping)
Foundational knowledge of cell biology, biochemistry, protein science, and/or chemistry
Strong attention to detail and excellent organizational skills
Effective teamwork and communication skills
Self-motivated with a positive, 'can-do' attitude
Able to multitask and adapt to shifting priorities
Preferred
Experience in purifying recombinant proteins
Experience in mammalian tissue culture
Experience in designing and carrying out biochemical and/or biophysical assays (TR-FRET, western blots, etc.)
Benefits
Monthly living expenses stipend
Company
Calico Life Sciences
Calico is an Alphabet-founded research and development company whose mission is to harness advanced technologies.
H1B Sponsorship
Calico Life Sciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (12)
2023 (7)
2022 (10)
2021 (5)
2020 (14)
Funding
Current Stage
Growth StageLeadership Team
Recent News
2025-11-15
2025-11-15
Company data provided by crunchbase